Health

  • July 24, 2026

    Federal Bill Seeks CDC Set-Aside For Tribal Health

    A coalition of U.S. lawmakers from New Mexico and U.S. Sen. Elizabeth Warren, D-Mass., have introduced legislation that would guarantee that tribal nations have equal access to the Centers for Disease Control and Prevention's Public Health Emergency Preparedness program.

  • July 24, 2026

    Yale Age Test, Allergy Death, Wine Royalties: A Midyear Report

    In the second half of 2026, Connecticut courts are being called upon to decide closely watched issues such as whether the state's largest hospital group violated federal disability and age discrimination laws when requiring providers over age 70 to undergo mandatory cognitive tests.

  • July 24, 2026

    Wellstar To Pay $4.25M To End Patient Data-Sharing Suit

    Wellstar Health System Inc. will pay $4.25 million to resolve a proposed class action alleging it used tracking and collection tools to share confidential health information with Meta Platforms and Google without patients' consent, according to a federal court filing.

  • July 24, 2026

    Mental Health Agency Sues Mass. Prison System For Records

    A Massachusetts mental health legal advocacy committee has filed a lawsuit against the state's department of correction, claiming it was denied access to data about health services provided in one state prison by a private contractor.

  • July 24, 2026

    Novo Asks NJ Judge To Stop Lilly's 'Deceptive' GLP-1 Ads

    Novo Nordisk Inc. asked a New Jersey federal court Friday to block rival Eli Lilly & Co. from running ads allegedly comparing their respective GLP-1 drugs using "outdated" clinical trials and "false superiority messages," arguing the ads are damaging its reputation and misleading consumers.

  • July 24, 2026

    Surgical Co. Trims Tobacco Fee Suit In Texas

    A Texas federal judge pared some claims from a proposed class action alleging that a surgical company wrongly imposed a surcharge on the health plans of workers who used tobacco, while opening discovery on other allegations she found had stated a claim for violating federal benefits law.

  • July 24, 2026

    Top Product Liability Cases Of 2026: Midyear Report

    In one of the most-watched cases for product liability so far this year, the U.S. Supreme Court ruled that failure-to-warn claims about the alleged cancer risks of Monsanto's widely used pesticide Roundup are barred by federal law. Social media titans were also rocked by the first verdicts delivered in cases alleging mental health harms to youth.

  • July 24, 2026

    Surgery Partners Stake Sale Values Idaho Hospitals At $1.2B

    Surgery Partners, an owner and operator of short-stay surgical facilities, said Friday it has reached a deal to sell its stake in two Idaho hospitals for nearly $800 million to Salt Lake City, Utah-based Intermountain Health.

  • July 24, 2026

    CVS Seeks Toss Of Hospitals' 340B Suits In NY, Mich.

    CVS urged New York and Michigan federal courts to toss separate suits brought by hospital operators accusing the health giant of diverting savings from the federal 340B Drug Pricing Program to itself, saying the suits purport to raise key questions about the program when they actually concern simple contract disputes.

  • July 24, 2026

    DOL E-Delivery Push Pleases Mgmt. And Worker Attys Alike

    Recently proposed U.S. Department of Labor regulations that would encourage e-delivery of employee health plan documents are winning plaudits from both sides of the benefits bar for potentially streamlining the process and augmenting online transparency. Here are three things to know about the DOL's proposal.

  • July 24, 2026

    Colo. Doctor Says Billing Co. Skimmed Pay, Mishandled Data

    A Colorado doctor has sued a medical billing company in state court, saying it mishandled patients' protected health information, skimmed her earnings and tried to pressure her into signing a new agreement allowing it to keep more collections after she left.

  • July 23, 2026

    NJ Panel Backs Doc In Malpractice Case Over Missed Cancer

    A New Jersey appeals court Thursday tossed a suit accusing a doctor of negligent medical treatment which led to a three-year delay of a patient's cancer diagnosis, saying the patient's medical expert did not properly allege that the delay caused harm.

  • July 23, 2026

    UnitedHealth's $5M Demand Challenged By Wash. Dental Co.

    A dental practice is urging a Washington federal court to stop UnitedHealth from withholding future reimbursements, saying the insurer has failed to fully explain its assertion that it overpaid the practice more than $5 million for past claims, in a lawsuit filed Wednesday.

  • July 23, 2026

    Okla. Chiropractor Convicted Of $30M Medical Fraud Scheme

    A Florida federal jury convicted an Oklahoma chiropractor of attempting to bilk $30 million from federal health insurance programs, finding him guilty of a fraud conspiracy charge after he obtained patient information to produce fake doctors' orders for unnecessary medical equipment, according to the U.S. Department of Justice.

  • July 23, 2026

    Texas Lab, Investors To Pay $24M In COVID-19 Testing Scheme

    Owners of a Dallas medical testing laboratory and their investors will altogether pay $24 million to resolve allegations that they ran afoul of the False Claims Act by submitting fraudulent claims to Medicare for unnecessary respiratory pathogen panel testing for seniors in assisted living facilities during the COVID-19 pandemic.

  • July 23, 2026

    Texas Panel Overturns Abortion Injunction Against Midwife

    A Texas appellate court overturned a temporary injunction against a licensed Houston-area midwife accused by state prosecutors of violating Texas' abortion ban, finding Thursday a trial court wrongly admitted probable-cause affidavits from a related criminal case.

  • July 23, 2026

    8th Circ. Says Vendor Didn't Show Major Harm In Bank IP Fight

    The Eighth Circuit on Thursday upheld a Missouri federal judge's refusal to block Commerce Bank from using software that a vendor alleges was developed with its trade secrets, ruling the vendor failed to show it was likely to suffer harm that could not be remedied later.

  • July 23, 2026

    3 Firms Guide Health Wellness Co.'s $650M SPAC Merger

    Health wellness company First Choice Healthcare Solutions announced that it has agreed to go public through a merger with special purpose acquisition company Western Acquisition Corp. in a $650 million deal built by three law firms.

  • July 23, 2026

    Target Sold Baby Formula That Caused Botulism, Parents Say

    Two parents claim their baby came down with infant botulism after drinking tainted whole milk powdered formula sold by Target and formula-maker Nara Organics, which later recalled the product amid an outbreak that sickened at least three other children, according to a lawsuit filed Thursday in Washington federal court.

  • July 23, 2026

    Abbott Labs Accused Of Lax Security Over Shinyhunters Hack

    Abbott Laboratories and Exact Sciences were hit with a proposed class action in Illinois federal court Wednesday over a cyberattack carried out by a notorious ransomware gang known as "Shinyhunters" that absconded with patients' medical records, which the suit says is far more harmful than standard identity theft.

  • July 23, 2026

    Mo. Panel Says Exclusion Bars Mallinckrodt Opioid Coverage

    A Missouri appellate court upheld a win for a group of insurers on their arguments that a "your products" policy exclusion applied to bar coverage of alleged damages from drugmaker Mallinckrodt's unbranded marketing of opioid products.

  • July 23, 2026

    Mass. Justices Say Health Board Can't Halt Verizon Tower

    A western Massachusetts city's health board lacked the power to order a Verizon cell tower to shut down due to health concerns, the state's highest court ruled Thursday.

  • July 23, 2026

    Kirkland, Sullivan & Cromwell Steer $2B ArisGlobal Deal

    Dassault Systèmes has agreed to acquire ArisGlobal, an AI-driven software provider for the life sciences industry, from private equity firm Nordic Capital for up to $2 billion, the companies said Thursday.

  • July 23, 2026

    Colo. Rehab Patients Sue Over Private Data Leak

    Patients of a Colorado rehabilitation medicine clinic filed a proposed class action in federal court over a ransomware attack that may have exposed their medical records, insurance information and other sensitive personal data.

  • July 22, 2026

    J&J Talc Plaintiffs Must Back Up Cancer Link Or Risk MDL

    Plaintiffs alleging Johnson & Johnson's talcum powder products caused ovarian cancer must show they can offer expert opinions on the link between the disease and talc use or risk having their lawsuits tossed, a New Jersey federal judge ruled Wednesday.

Expert Analysis

  • The Evolution Of States' Workplace Violence Prevention Laws

    Author Photo

    Utah's new law requiring hospitals to implement comprehensive workplace violence reporting systems continues a broader trend of state efforts to expand workplace protections in the absence of sufficient federal regulations, say attorneys at Ogletree.

  • Series

    Alpine Skiing Makes Me A Better Lawyer

    Author Photo

    Skiing has shaped habits I rely on daily as an attorney — focus, resilience and the ability to remain steady when circumstances shift rapidly — and influences the way I approach legal strategy, client counseling and teamwork, says Isaku Begert at Marshall Gerstein.

  • Weighing The Practical Implications Of SC Kids' Privacy Law

    Author Photo

    South Carolina's recently enacted Age-Appropriate Code Design Act includes a unique provision: a private right of action for certain violations, but its practical effect remains uncertain, as courts and litigants grapple with complex questions of standing, causation and the definition of actionable harm, say attorneys at K&L Gates.

  • FDA Guidance May Move Goalposts For Form 483 Responses

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers are expected to respond to Form 483s, raising some concerns about the agency's timelines and expectations, say attorneys at Cooley.

  • 2 Strands Of Patent Law In High Court's 'Skinny Label' Case

    Author Photo

    Amarin v. Hikma, which is set for oral argument in the U.S. Supreme Court this month, highlights the distinction between two different strands of intellectual property law — analogizing a patent to either a property deed or a home, says Jonas McDavit at Spencer West.

  • Telehealth Suit May Redraw Rules For Physician Classification

    Author Photo

    A new class action in California federal court, Cioppettini v. Mochi Medical, alleging a telehealth company misclassified providers as independent contractors, suggests that traditional markers of physician independence may not apply to telehealth, say attorneys at Reed Smith.

  • Legal Theories In Social Media Verdicts Hold Clues On Impact

    Author Photo

    Although the two verdicts in cases in New Mexico and California involving Meta and Google are being lumped together, they rest on fundamentally different legal theories, and that distinction determines how their effects may be felt in other jurisdictions, says Mark Morgan at Day Pitney.

  • Senior Housing Demands A Distinct Dealmaking Playbook

    Author Photo

    An aging population and evolving state regulations underscore a critical reality that senior housing assets can undergo operational or compliance shifts during dealmaking, highlighting the need for unique contractual safeguards like expanded disclosures, anchored notice obligations, and targeted closing conditions and remedies, say attorneys at Goodwin.

  • Why MDLs Slow Down — And How To Speed Them Up

    Author Photo

    Multidistrict litigation has become central to mass tort practice, but as MDLs grow in size and complexity, so do delays and costs — so tools like the new federal rule governing MDLs, targeted use of special masters and strategically deployed Lone Pine orders are more essential than ever, say attorneys at Ice Miller.

  • A Check-Up On HHS' Push To Implement AI Infrastructure

    Author Photo

    The U.S. Department of Health and Human Services has made some headway in its efforts to implement artificial intelligence across its agencies, but will have to overcome a number of near-term tests in order to be successful, says Theodore Thompson at Stinson.

  • What A Court Doc Audit Reveals About Erroneous Filings

    Author Photo

    My audit of 1,522 court documents from last month found that over 95% contained at least one verifiable error, with fewer than 1% showing clear indicators of artificial intelligence use — highlighting above all else that lawyers may want to focus most on strengthening their review processes, says Elliott Ash at ETH Zurich.

  • Exploring When Fraud Asset Freezes Limit Right To Pick Atty

    Author Photo

    The defendant’s claim in the Seventh Circuit’s pending U.S. v. Shah case that the government restrained his assets until he couldn’t afford his chosen counsel presents a useful case study in how criminal forfeiture procedure interacts with U.S. Supreme Court rulings on Sixth Amendment rights and appealing complex fraud convictions, says Elisha Kobre at Sheppard.

  • Similar-Looking Designs May Not Always Prove Infringement

    Author Photo

    The Federal Circuit's recent decision in Range of Motion Products v. Armaid is a reminder that even a strikingly similar design might not be found to infringe upon a patented design once design features driven by functionality are filtered out from consideration, say attorneys at BCLP.

  • Series

    Mich. Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    Michigan's financial services sector saw several significant developments in 2026's first quarter, including the state Department of Insurance and Financial Services' issuance of a bulletin on the use of artificial intelligence and the Michigan House's introduction of a bill based on the Model Money Transmission Modernization Act, say attorneys at Dykema.

  • The Road Ahead For Drug Development In The US

    Author Photo

    Against the backdrop of drug manufacturers potentially looking to move development efforts overseas, the U.S. Food and Drug Administration's latest guidance on new approach methodologies signals the FDA is likely to be receptive to industry innovation that makes U.S.-based drug development faster or less expensive, creating opportunities and compliance risks for tech companies, say attorneys at Morgan Lewis.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.